Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07631416Phase 4Not yet recruiting
Phase 4 trial of bupivacaine in postoperative pain (2 arms), sponsored by Sohag University. Primary endpoint: Visual Analogue Scale score for postoperative pain at 24 hours. Planned start May 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07631416.